Neoadjuvant Immunotherapy: A Promising New Standard of Care

Neoadjuvant immunotherapy has emerged as a promising approach in the treatment of various malignancies, with preclinical studies showing improved immune responses in the preoperative setting. FDA-approved neoadjuvant-immunotherapy-based approaches include triple-negative breast cancer and early non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Boydell, Emma, Sandoval, Jose L., Michielin, Olivier, Obeid, Michel, Addeo, Alfredo, Friedlaender, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380420/
https://www.ncbi.nlm.nih.gov/pubmed/37511609
http://dx.doi.org/10.3390/ijms241411849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380420/
https://www.ncbi.nlm.nih.gov/pubmed/37511609
http://dx.doi.org/10.3390/ijms241411849

Ejemplares similares